Market Tracker

04/29 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

17.38
Delayed Data
As of Apr 29
 -0.85 / -4.66%
Today’s Change
12.25
Today|||52-Week Range
33.74
-4.14%
Year-to-Date

Today’s Trading

Previous close18.23
Today’s open18.30
Day’s range17.06 - 18.72
Volume1,942,290
Average volume (3 months)1,921,626
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+94.02%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.88+3.27%
DNAIProNAi Therapeutics ...-0.18-3.11%
OASMOasmia Pharmaceutica...+0.38+8.79%
NEPTNeptune Technologies...+0.05+4.20%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts